INGN
Inogen, Inc.
Medical Devices · Healthcare · United States
6.86
close · 2026-10-30
value
33
cheaper than peers33
quality
51
stronger fundamentals51
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.52× | 88 |
| price to book | 1.05× | 84 |
| cash flow yield, 1 year ago | -6.1% | 43 |
| earnings yield, latest year | -12.5% | 42 |
| earnings yield, 1 year ago | -22.2% | 37 |
| cash flow yield, latest year | -11.9% | 31 |
| cash flow yield, 2 years ago | -16.6% | 30 |
| earnings yield, 3 years ago | -53.5% | 24 |
| cash flow yield, 3 years ago | -32.3% | 22 |
| earnings yield, 2 years ago | -64.4% | 20 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 9.3% | 77 |
| return on equity | -13.1% | 53 |
| operating margin | -9.9% | 40 |
| revenue growth | 3.4% | 35 |
4 of 4 measures available
Facts
| market cap | $182M |
| free cash flow | -$2.4M |
| employees | 753 |
| first trade | 2014-02-14 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.86 | -1.52 | -4.42 | -3.67 |
| free cash flow | -$21.6M | -$11.2M | -$30.2M | -$58.8M |
| net income | -$22.7M | -$35.9M | -$102.4M | -$83.8M |
| revenue | $348.7M | $335.7M | $315.7M | $377.2M |
| unusual items | $0 | $0 | -$32.9M | -$52.2M |